Mellitus Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 9

Mellitus General Information

Description

Developer of diabetes detection and monitoring device designed to detect gestational diabetes. The company's device is used for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis, and monitoring of diabetes, stratification of complications risk, and as a clinical trial test for pharmaceutical development, thereby enabling users to identify the potential risk of gestational diabetes mellitus within minutes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • CIC Boston
  • 50 Milk Street
  • Boston, MA 02109
  • United States
+1 (617) 000-0000

Mellitus Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mellitus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 16-Sep-2020 $1M 000.00 Completed Generating Revenue
6. Grant 01-Jan-2020 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 07-May-2019 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 02-Oct-2018 000 000.00 Completed Generating Revenue
3. Later Stage VC 08-May-2017 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 $2.22M Completed Generating Revenue
1. Early Stage VC 02-Oct-2013 $2.22M $2.22M Completed Generating Revenue
To view Mellitus’s complete valuation and funding history, request access »

Mellitus Patents

Mellitus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3612625-A4 Methods and antibodies for diabetes-related applications Pending 21-Apr-2017 00000000000
JP-2020517306-A Methods and antibodies for diabetes related uses Pending 21-Apr-2017 00000000000 0
AU-2018255244-A1 Methods and antibodies for diabetes-related applications Pending 21-Apr-2017 00000000000
EP-3612625-A1 Methods and antibodies for diabetes-related applications Pending 21-Apr-2017 00000000000
US-20210284751-A1 Methods and antibodies for diabetes-related applications Pending 21-Apr-2017 G01N33/6893
To view Mellitus’s complete patent history, request access »

Mellitus Executive Team (6)

Name Title Board Seat Contact Info
Jose Halperin MD Co-Founder & Board Member
Michael Chorev Ph.D Co-Founder & Board Member
Kathy Welch Head of Finance
Linda Bowers Assistant, Administration
John Tagliamonte Chief Executive Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Mellitus Board Members (6)

Name Representing Role Since
Christopher De Souza Ph.D Broadview Ventures Board Member 000 0000
Hunterson Henrie II Self Board Member 000 0000
Jose Halperin MD Mellitus Co-Founder & Board Member 000 0000
Michael Chorev Ph.D Mellitus Co-Founder & Board Member 000 0000
Xing Zhao Ph.D Mellitus Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Mellitus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mellitus Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Binhai Venture Capital Venture Capital Minority 000 0000 000000 0
Dreamers VC Venture Capital Minority 000 0000 000000 0
Orient Life Corporation Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »